Biotechnology and bioengineering – Page 14
-
ResearchHuman genome sequenced by handheld device
MinION nanopore sequencer fills in gaps in our knowledge of genome
-
-
NewsExplainer: non-alcoholic beer and wine
For Dry January and beyond, drinkers are thirsty for beers and wines that don’t get you drunk
-
ResearchIndigo genes dyeing to make jeans cleaner and greener
Denim dye could become more environmentally friendly with some clever chemistry
-
ResearchSynthetic gene cost slashed to $2
DropSynth makes hundreds of strands in a single tube, boosting tests of gene function
-
-
ResearchScrutiny of SmartFlares raises questions over RNA probes
Merck Millipore technology for detecting specific RNAs may not live up to claims
-
ResearchError-free next-generation DNA sequencing pioneered
Algorithmic fix allows ultra-accurate sequencing of rare cancers and genetic conditions
-
BusinessLilly and CureVac to collaborate on mRNA cancer vaccines
Deal could see CureVac net up to $1.8 billion in upfront and milestone payments
-
ResearchPeptide vehicle drives Crispr delivery of Cas9 into cells
Gene editing enzyme ferried via endocytic pathway
-
ResearchCrispr gene editor can now alter RNA as well as DNA
Gene editing technique is developing apace with two new technologies unveiled
-
OpinionRise of the biologics
Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
-
PodcastA Crack in Creation by Jennifer Doudna – Book club
The development of Crispr, and the ethical questions raised by new genome editing techniques
-
BusinessUS to invest $160m in cancer partnership
Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system
-
BusinessBASF to buy Bayer seeds and herbicides
€5.9bn sale will help satisfy competition regulators’ worries over Bayer–Monsanto merger
-
ResearchFirst for cells as they're made to manufacture fluorinated bioplastics
Genetically modified bacteria could make synthesis of new materials more sustainable
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
BusinessTakeda tightens focus on core areas with multiple deals
Japanese firm is remodelling its R&D efforts through collaboration and licensing deals, and selling off non-core businesses
-
ResearchGut bugs hijacking our signalling could treat disease
Gastrointestinal microflora found to produce a profusion of molecules that can affect human health